Today: 7 February 2026
Subscribe
Browse Category

Mergers and Acquisitions News 15 December 2025 - 21 December 2025

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow, Inc. (NYSE: NOW) heads into the week of December 22–26, 2025 with momentum in its product narrative—but also with headline risk that has recently dominated the stock. The company has closed its largest acquisition to date (Moveworks), announced a security-focused buyout of identity specialist Veza, and completed a 5-for-1 stock split—all while markets digest reports that ServiceNow is in advanced talks to buy cybersecurity firm Armis for up to $7 billion. Reuters+3ServiceNow Newsroom+3ServiceNow Newsroom+3 With U.S. markets entering a holiday-shortened, potentially low-liquidity week—and with macro data still on the calendar—ServiceNow stock could be especially sensitive to incremental headlines, analyst
21 December 2025
·····
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Latest News, Analyst Forecasts, and What Comes Next (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (Nasdaq: FOLD) has effectively become a “deal stock” — the market is now trading the shares primarily on the odds and timing of a takeover rather than on classic biotech catalysts. The reason is simple: on December 19, 2025, BioMarin Pharmaceutical announced a definitive agreement to acquire Amicus for $14.50 per share in cash, valuing Amicus at about $4.8 billion. SEC+1 With U.S. markets closed this weekend, the last meaningful read is Friday’s action: Market data services show Amicus closing around $14.20 on Dec. 19, with trading also widely reported near
21 December 2025
······
Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics (FOLD) Stock Jumps on BioMarin’s $4.8B Buyout: Latest News, Forecasts, and Deal Analysis as of Dec. 20, 2025

Amicus Therapeutics, Inc. (NASDAQ: FOLD) has become one of the most closely watched rare-disease stocks heading into the final stretch of 2025 after BioMarin Pharmaceutical announced a definitive agreement to acquire Amicus in an all-cash transaction valued at about $4.8 billion. The offer price—$14.50 per share in cash—instantly reset the “center of gravity” for FOLD shares and shifted investor focus from traditional biotech catalysts (quarterly launches, pipeline readouts, reimbursement updates) to merger timing, regulatory approvals, and closing risk. SEC+1 As of the latest available pricing around Dec. 20, 2025 (UTC), Amicus shares were trading around $14.18, after a sharp, deal-driven
21 December 2025
·····
Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Warner Bros. Discovery Stock (WBD) Forecast: Netflix Merger vs. Paramount’s $30 Bid Puts Shares in Deal-Driven Limbo (Dec. 20, 2025)

Date: December 20, 2025Company: Warner Bros. Discovery, Inc. (NASDAQ: WBD) Warner Bros. Discovery stock is no longer trading like a “normal” media equity. As of this weekend, WBD shares are moving like a merger-arbitrage instrument, tethered to two competing takeover paths: Netflix’s signed deal for WBD’s Studios + Streaming assets and Paramount Skydance’s hostile all-cash tender offer for the entire company. Reuters+2Warner Bros. Discovery IR+2 At the close on Friday, Dec. 19, WBD finished at $27.77 (after a session that saw heavy volume and a trading range roughly between the high-$27s and $28.50). StockAnalysis That closing price sits just pennies
21 December 2025
······
Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

Communication Services Stocks News Today (Dec. 20, 2025): Meta, Alphabet, Netflix–Warner Deal Shockwaves, and Telecom M&A Set Up 2026

December 20, 2025 — Communication Services stocks head into the final stretch of 2025 with a rare mix of forces pulling in different directions at once: platform-driven advertising growth, mega-deal consolidation in streaming and media, and regulator-heavy telecom transactions that can reshape fiber, wireless, and spectrum markets in 2026. The sector is broad by design. The State Street Communication Services Select Sector SPDR ETF (XLC)—a widely used proxy—spans interactive media & services, entertainment, media, and telecom. Its latest published holdings snapshot shows Meta Platforms and Alphabet as the largest weights, alongside a fast-changing entertainment/media block that now includes Warner Bros.
20 December 2025
············
Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Acquisition Closes, Analyst Targets Update, and 2026 AI Data-Center Outlook (Dec. 19, 2025)

Qualcomm Incorporated (NASDAQ: QCOM) is back in focus on Friday, December 19, 2025, as investors digest a fresh wave of M&A-related headlines, valuation debates, and shifting expectations for Qualcomm’s next growth chapter beyond smartphones. As of Dec. 19, 2025 (17:26 UTC), Qualcomm stock traded at about $176.58, up roughly 1.37% versus the prior close, with the day’s range roughly $173.60 to $177.19. What’s driving Qualcomm stock on December 19, 2025? Three storylines are shaping the QCOM conversation today: The Alphawave Semi acquisition: why QCOM investors care now Qualcomm’s messaging around Alphawave is unusually specific: the company explicitly tied Alphawave Semi’s
19 December 2025
······
Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings (HHH) Stock Falls on Dec. 19, 2025 After $2.1B Vantage Deal: Latest News, Analyst Forecasts, and Key Risks

Howard Hughes Holdings Inc. (NYSE: HHH) stock traded sharply lower on Friday, Dec. 19, 2025, as investors digested the company’s headline-grabbing move to buy specialty insurer and reinsurer Vantage Group Holdings in a deal valued at about $2.1 billion. HHH shares were hovering around $79–$80, down roughly 5% on the day, after opening near $84. Investing.com The decline comes one session after the announcement sparked a more upbeat first reaction in parts of the market, highlighting the core tension in today’s Howard Hughes story: HHH is no longer pitching itself as “just” a real estate developer—it’s pitching itself as the
19 December 2025
·····
TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

TWO-PA Stock News Today (Dec. 17, 2025): UWM’s $1.3B Two Harbors Deal Puts Series A Preferred in Focus — What Holders Need to Know

Two Harbors Investment Corp.’s Series A fixed-to-floating preferred stock — commonly shown by brokers and data vendors as TWO-PA, TWO.PRA, or TWO PRA — is drawing unusual attention on December 17, 2025 after a major corporate action: UWM Holdings Corporation (NYSE: UWMC) and Two Harbors Investment Corp. (NYSE: TWO) announced a definitive agreement for UWM to acquire Two Harbors in an all-stock transaction valued at about $1.3 billion. SEC+1 For preferred holders, the headline detail is clear and highly material: each share of Two Harbors’ Series A preferred stock will be exchanged for one share of a newly issued UWM
17 December 2025
·····
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

December 16, 2025 — ABIVAX Société Anonyme (listed as ABVX on Euronext Paris and Nasdaq) is back in the spotlight today after publishing third-quarter 2025 financial results and reiterating a long cash runway—news that didn’t stop the stock from pulling back as investors digested widening losses and the sheer scale of the rally already priced in. In U.S. trading, Abivax’s Nasdaq-listed shares were down about 5% around mid-session, at roughly $111–$112. StockAnalysis In Paris, Abivax shares were also lower earlier in the day, with one market report citing a drop of about 5.7% during the European morning. Investing.com South Africa
16 December 2025
·····
Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola Stock (NYSE: KO) News Today: Costa Coffee Sale Talks, CEO Succession, Dividend, and Analyst Price Targets (Dec. 15, 2025)

Coca-Cola Company (The) stock (NYSE: KO) is back in the spotlight on December 15, 2025, as investors balance deal chatter around Costa Coffee, a high-profile CEO transition, and a dividend payday—all while Wall Street’s consensus outlook continues to point to modest upside from current trading levels. As of the latest U.S. session update, KO traded around $70.72, up about 0.28% on the day, after moving between $70.30 and $71.31. Below is a full, publication-ready roundup of today’s key Coca-Cola stock news, company guidance, and the most-cited analyst forecasts and price targets shaping sentiment around KO right now. KO stock price
15 December 2025
·····
ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

ServiceNow (NOW) Stock Slides on Armis Deal Rumors, KeyBanc Downgrade, and a Looming 5-for-1 Split

December 15, 2025 — ServiceNow, Inc. (NYSE: NOW) took a sharp hit in Monday trading as investors digested two heavyweight headlines at once: a report that the workflow-software leader is nearing a potential $7 billion acquisition of cybersecurity startup Armis, and a fresh analyst downgrade from KeyBanc warning that AI-driven disruption could pressure the traditional software-as-a-service (SaaS) playbook. Barron’s+1 In early afternoon U.S. trading, ServiceNow stock was around $767, down roughly 11% on the session after swinging between about $849 and $767. The selloff also comes just days before ServiceNow’s 5-for-1 stock split, which is expected to take effect this
15 December 2025
·····
Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

Aegon Ltd Stock (AEG) Today: Transamerica Rebrand, U.S. Relocation Plan, Buybacks, and the UK Sale Watchlist (Dec. 15, 2025)

December 15, 2025 — Aegon Ltd stock is trading in a market that’s still digesting one of the company’s biggest strategic pivots in decades: a plan to move its head office and legal seat to the United States and ultimately rename the holding company Transamerica Inc. by January 1, 2028. SEC+1 As of Monday’s U.S. session, Aegon’s New York registry shares were recently around $7.63 (midday), reflecting how quickly sentiment can swing when investors are forced to price both a growth story and a “transition period” bill. StockAnalysis What makes Aegon Ltd stock especially interesting on 15.12.2025 isn’t just the
15 December 2025
·····
1 2 3 4 5 6 … 10

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop